Aleksandra Galetin - Concepedia

Author

Aleksandra Galetin

University of Manchester ORCID

Also Known As

A Galetin, A. Galetin, Aleksandra Galetin, Galetin, A, Galetin, Aleksandra

246

Publications

9.4K

Citations

H-Index

Concepts

All Affiliations

University of Manchester Simcyp (United Kingdom)Manchester Academic Health Science Centre Roche (Switzerland)AstraZeneca (United Kingdom)

About

Aleksandra Galetin is an author at University of Manchester specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	27	1.4K
2	Engineering	4	4	300
3	Health Sciences	1	1	29
4	Natural Sciences	1	1	55
5	Public Health	1	1	33

Aleksandra Galetin

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID Verawan Uchaipichat, Peter I. Mackenzie, Xiao-Hui Guo, Drug Metabolism and Disposition	2004	333
Prediction of Human Intestinal First-Pass Metabolism of 25 CYP3A Substrates from In Vitro Clearance and Permeability Data Michael Gertz, Anthony Harrison, J. Brian Houston, Drug Metabolism and Disposition	2010	295
Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data Hannah M. Jones, Hugh A. Barton, Yurong Lai, Drug Metabolism and Disposition	2012	241
ISOFORM SELECTIVITY AND KINETICS OF MORPHINE 3- AND 6-GLUCURONIDATION BY HUMAN UDP-GLUCURONOSYLTRANSFERASES: EVIDENCE FOR ATYPICAL GLUCURONIDATION KINETICS BY UGT2B7 Andrew N. Stone, Peter I. Mackenzie, Aleksandra Galetin, Drug Metabolism and Disposition	2003	203
Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver Microsomes Peter Kilford, Rowan Stringer, Bindi Sohal, Drug Metabolism and Disposition	2008	186
Critique of the Two-Fold Measure of Prediction Success for Ratios: Application for the Assessment of Drug-Drug Interactions Eleanor J. Guest, Leon Aarons, J. Brian Houston, Drug Metabolism and Disposition	2010	185
Hepatocellular Binding of Drugs: Correction for Unbound Fraction in Hepatocyte Incubations Using Microsomal Binding or Drug Lipophilicity Data Peter Kilford, Michael Gertz, J. Brian Houston, Drug Metabolism and Disposition	2008	168
PREDICTION OF TIME-DEPENDENT CYP3A4 DRUG-DRUG INTERACTIONS: IMPACT OF ENZYME DEGRADATION, PARALLEL ELIMINATION PATHWAYS, AND INTESTINAL INHIBITION Aleksandra Galetin, Howard Burt, Laura E. Gibbons, Drug Metabolism and Disposition	2005	161
CYP3A4 Substrate Selection and Substitution in the Prediction of Potential Drug-Drug Interactions Aleksandra Galetin, Kiyomi Ito, David Hallifax, Journal of Pharmacology and Experimental Therapeutics	2005	155
Intestinal and Hepatic Metabolic Activity of Five Cytochrome P450 Enzymes: Impact on Prediction of First-Pass Metabolism Aleksandra Galetin, J. Brian Houston Journal of Pharmacology and Experimental Therapeutics	2006	154

Page 1